Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 22.59B | 21.27B | 19.47B | 16.91B | 17.17B |
Gross Profit | 9.88B | 9.86B | 8.12B | 6.65B | 7.16B |
EBITDA | 4.22B | 4.48B | 3.65B | 3.44B | 2.32B |
Net Income | 2.11B | 2.23B | 2.21B | 2.14B | 1.14B |
Balance Sheet | |||||
Total Assets | 69.82B | 66.61B | 53.00B | 50.68B | 51.65B |
Cash, Cash Equivalents and Short-Term Investments | 9.01B | 11.91B | 14.37B | 16.41B | 17.11B |
Total Debt | 5.59B | 6.24B | 3.92B | 3.09B | 4.69B |
Total Liabilities | 18.64B | 18.89B | 12.85B | 11.02B | 13.32B |
Stockholders Equity | 50.83B | 47.39B | 39.83B | 39.36B | 37.94B |
Cash Flow | |||||
Free Cash Flow | -150.00M | -2.05B | 2.64B | 2.36B | 2.39B |
Operating Cash Flow | 1.11B | 3.20B | 2.77B | 2.39B | 2.50B |
Investing Cash Flow | -817.00M | -5.93B | -1.52B | -457.00M | 1.13B |
Financing Cash Flow | -3.10B | -421.00M | -3.38B | -2.72B | -1.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥41.46B | 11.62 | 4.35% | 5.12% | 55.73% | ||
74 Outperform | ¥39.47B | 14.82 | 2.81% | -5.75% | 49.48% | ||
72 Outperform | ¥25.51B | 12.06 | 4.20% | 3.81% | -4.07% | ||
68 Neutral | ¥37.56B | 29.49 | 4.73% | 31.10% | -3.78% | ||
67 Neutral | ¥24.61B | 25.50 | 1.12% | 5.70% | -12.06% | ||
61 Neutral | $17.23B | 11.51 | -5.97% | 3.09% | 1.37% | -15.81% | |
60 Neutral | ¥28.63B | ― | 4.77% | -4.39% | -894.94% |